An Insight into Chickpea-Derived Secondary Metabolites as Functional and Nutraceutical Agents against Diabetes.

Iraj Fatima, Muhammad Kashif Iqbal Khan, Abid Aslam Maan, Sharmeen Arif

Abstract readReview

In one paragraph

Review in Plant foods for human nutrition (Dordrecht, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Chickpea (Foods (Basel, Switzerland) · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Iraj FatimaNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, 38000, Pakistan. irajfatima1130@gmail.com.

Muhammad Kashif Iqbal KhanNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, 38000, Pakistan.

Abid Aslam MaanNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, 38000, Pakistan.

Sharmeen ArifNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, 38000, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Legumes are a main source of sustainable, inexpensive protein, dietary fiber, phytochemicals, micronutrients, and bioactive components. Among them, chickpeas hold a significant place in terms of production and consumption. The review focuses on the functional activity of chickpeas as a rich source of polyphenols and flavonoids, exploring their potential effects against diabetes. The consumption of chickpeas in various forms, such as bakery items, chapatti, weaning foods, plant-based beverages, flour, and extruded snacks, is considered healthy. Chickpea-based diets generally have a low glycemic index, which is beneficial for preventing metabolic syndrome and managing diabetes. This review specifically highlights the phytochemical composition of chickpeas, emphasizing their bio-pharmacological properties against a highly prevalent disease, i.e., diabetes. Furthermore, Cicer arietinum Linn. plays a significant role in controlling blood sugar by enhancing beta cell function, which regulates insulin production through the GLUT

Indexed as

CicerDiabetes Mellitus, Type 2Dietary SupplementsHypoglycemic AgentsBlood GlucoseFlavonoidsHumansInsulinPhytochemicalsPolyphenolsBlood GlucoseFlavonoidsHypoglycemic AgentsInsulinPhytochemicalsPolyphenolsChickpeaDiabetes type 2Functional foodHyperglycemiaPhytonutrients

Identifiers

PMID41032188

DOI10.1007/s11130-025-01399-4

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.